Naloxone ADR Reviews

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to cmichalek@ismp.org

6 posts / 0 new
Last post
Manisa Tanprayoon
Manisa Tanprayoon's picture
Offline
Last seen: 2 weeks 5 days ago
Joined: 03/08/2020 - 09:40
Naloxone ADR Reviews

Hello MSOS Members,

We have very low number of ADR reporting and one of the ideas is to review naloxone use after opioid administrations during hospitalizations. Would you mind sharing how you do it (if you include naloxone in your ADR data)?

Thank you in advance for your time,

Manisa